The government has quietly scaled down projections of how many AstraZeneca doses will be available in Australia in the coming weeks, while downplaying a huge gap between the amount being locally produced and original Covid-19 vaccine supply targets. Both forecasts are more than double the actual level of production of AstraZeneca vaccine planned by Australia’s domestic vaccine manufacturer, CSL. CSL production in the past month has also been well down on its usual levels. Production fell from the 1m doses a week in May to 232,000 in the week commencing 7 June. “The commonwealth does not anticipate any difficulties in supply of locally produced AstraZeneca vaccine,” a spokesman said.

Source: The Guardian July 15, 2021 06:45 UTC